Inventor
Benjamin H. Dutzar
Inventor
Seattle, WA, US
Overview
Patents· 61 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C07KPeptides27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
Y02ATechnologies for adaptation to climate change11%
C12NMicroorganisms or enzymes8%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
11,117,960Humanized anti-ACTH antibodies and use thereof202111,111,289Anti-CGRP compositions and use thereof202110,981,985Anti-PACAP antibodies202110,981,984Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion202110,975,135Humanized anti-PACAP antibodies202110,968,268Humanized anti-PACAP antibodies202110,954,285Humanized anti-PACAP antibodies202110,913,794Antibodies to IL-6 and use thereof202110,913,783Humanized anti-PACAP antibodies and uses thereof202110,899,834Anti-PACAP antibodies202110,844,116Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia202010,800,841Methods of treating autoimmunity using specific anti-IL-6 antibodies202010,759,853Antibodies to IL-6 and use thereof202010,550,180Anti-ACTH antibodies and use thereof202010,544,214Humanized anti-ACTH antibodies and use thereof202010,533,048Anti-CGRP compositions and use thereof202010,457,727Methods of preventing inflammation and treating pain using anti-NGF compositions201910,391,169Method of treating allergic asthma with antibodies to IL-6201910,344,083Anti-NGF compositions and use thereof201910,344,086Antibodies to IL-6 and use thereof201910,259,885Anti-PCSK9 antibodies and use thereof201910,233,239Isolated host cells expressing anti-IL-6 antibodies201910,227,402Anti-NGF antibodies and anti-NGF antibody fragments201910,221,236Anti-NGF antibodies that selectively inhibit the association of NGF with TRKA without affecting the association of NGF with P75201910,214,582Anti-CGRP compositions and use thereof201910,208,112Anti-CGRP compositions and use thereof201910,202,435Anti-PACAP antibodies and uses thereof201910,189,895Anti-CGRP compositions and use thereof201910,179,813Methods of determining whether anti-PACAP (adenylate cyclase-activating peptide) antibodies or anti-PACAP antigen binding fragments inhibit PACAP-associated photophobia or light aversion201910,179,809Anti-CGRP compositions and use thereof201910,117,955Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies201810,100,108Antibodies to HGF and compositions containing201810,066,009Anti-CGRP compositions and use thereof201810,047,157Humanized anti-ACTH antibodies and use thereof20189,890,214'Antibodies to TNF α and use thereof'20189,884,912'Antibodies to IL-6 and use thereof'20189,884,909'Anti-NGF compositions and use thereof'20189,879,074'Antibodies to IL-6 and use thereof'20189,834,603Antibodies to IL-6 and use thereof20179,783,602'Anti-NGF compositions and use thereof'20179,783,603'Therapeutic use of antibodies to HGF'20179,783,601'Methods of preventing inflammation and treating pain using anti-NGF compositions'20179,775,921'Subcutaneously administrable composition containing anti-IL-6 antibody'20179,771,421'Treating anemia in chronic IL-6 associated diseases using anti-IL-6 antibodies'20179,745,373'Anti-CGRP compositions and use thereof'20179,738,713'Methods of preventing or treating pain using anti-NGF antibodies'20179,732,150'Therapeutic use of antibodies to HGF'20179,725,509'Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibody'20179,718,882'Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with P75'20179,688,754'Anti-ACTH antibodies and use thereof'20179,539,324'Methods of preventing inflammation and treating pain using anti-NGF compositions'20179,499,611'Anti-NGF compositions and use thereof'20169,481,725'Antibodies to HGF and compositions containing'20169,359,432'Methods of preventing or treating pain using anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75'20169,255,154'Anti-PCSK9 antibodies and use thereof'20169,085,615'Antibodies to IL-6 to inhibit or treat inflammation'20159,078,878'Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75'20159,067,988'Methods of preventing or treating pain using anti-NGF antibodies'20159,062,104'Therapeutic use of antibodies to HGF'20158,911,734'Methods of preventing or treating pain using anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75'20148,728,473'Methods of preventing or treating pain using anti-NGF antibodies'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2021Patents assigned to ALDERBIO HOLDINGS LLC (48)· patent assignee history
2014–2017Patents assigned to DUTZAR BENJAMIN H (6)· patent assignee history
2014–2017Patents assigned to GARCIA-MARTINEZ LEON F (6)· patent assignee history
2014–2021Based in Seattle, WA, US· patent location history
2017–2021Patents assigned to ALDER BIOPHARMACEUTICALS INC (7)· patent assignee history
2020–2021Patents assigned to H LUNDBECK AS (10)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALDERBIO HOLDINGS LLC | 48 | 2014–2021 |
| H LUNDBECK AS | 10 | 2020–2021 |
| ALDER BIOPHARMACEUTICALS INC | 7 | 2017–2021 |
| DUTZAR BENJAMIN Hself | 6 | 2014–2017 |
| GARCIA-MARTINEZ LEON F | 6 | 2014–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Seattle, Washington, US | 61 | 2014–2021 |